T-cell activator offers protection against coronaviruses in immunocompromised cancer patients
Good news for patients with acquired or congenital immunodeficiency: The results of a clinical phase II study at the University Hospital Tübingen led by Prof. Dr. Juliane Walz and Prof. Dr. Helmut Salih show an effective ...
Aug 25, 2023
0
27